• BioMarin Pharmaceutical average return on investment for 2023 was 2.14, a 47.59% increase from 2022.
• BioMarin Pharmaceutical average return on investment for 2022 was 1.45, a 81.22% increase from 2021.
• BioMarin Pharmaceutical average return on investment for 2021 was 7.72, a 31.56% decline from 2020.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.